Morgan Stanley Upgrades Invivyd to Overweight, Raises Price Target to $10
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Maxwell Skor upgraded Invivyd (NASDAQ:IVVD) from Equal-Weight to Overweight and increased the price target from $4 to $10.
March 26, 2024 | 9:28 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Morgan Stanley upgraded Invivyd from Equal-Weight to Overweight and raised the price target from $4 to $10.
Upgrades by major financial institutions like Morgan Stanley typically lead to increased investor confidence and can drive up the stock price in the short term. The significant raise in price target from $4 to $10 reflects a strong positive outlook on the company's future performance, likely leading to increased buying activity and upward price movement.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100